Evidence map›Paper›PMID 17345123›Full record

ReviewWorld journal of surgery2007

Development of small-diameter vascular grafts.

Xinwen Wang, Peter Lin, Qizhi Yao, Changyi Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of surgery, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 210 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Biomaterials science · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Development of drug loaded cardiovascular prosthesis for thrombosis prevention using 3D printing.Materials science & engineering. C, Materials for biological applications · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xinwen WangMolecular Surgeon Research Center, Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, NAB-2010, Houston, Texas 77030, USA.
Peter Lin
Qizhi Yao
Changyi Chen
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTIONR01HL065916 · NHLBI · EMORY UNIVERSITY · PI CHEN, CHANGYI · 2000 to 2004
$1.8M
Tissue engineering of small diameter vascular graftR01EB002436 · NIBIB · BAYLOR COLLEGE OF MEDICINE · PI CHEN, CHANGYI · 2003 to 2006
$1.8M
Effects of HAART drugs on endothelial dysfunction of pu*R01HL083471 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, CHANGYI · 2005 to 2009
$1.8M
Effects of HIV Protease Inhibitors of Endothelial BarrieR01HL072716 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, CHANGYI · 2002 to 2005
$1.2M
Influenza HA in SHIV VLPS for mucosal vaccinationR01DE015543 · NIDCR · BAYLOR COLLEGE OF MEDICINE · PI YAO, QIZHI C. · 2003 to 2006
$1.2M
Homocysteine/Hypertension &Vascular Lesion FormationK08HL076345 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LIN, PETER H · 2004 to 2008
$649k
Ginkgo Biloba Enhances Therapeutic HIV VaccinationR21AT003094 · NCCIH · BAYLOR COLLEGE OF MEDICINE · PI YAO, QIZHI C. · 2005 to 2006
$371k
NCCIH NIH HHS AT003094NHLBI NIH HHS HL076345NHLBI NIH HHS HL083471NHLBI NIH HHS HL65916NHLBI NIH HHS HL72716NIBIB NIH HHS EB-002436NIDCR NIH HHS DE15543
6 · The paper itself

Abstract

introductionCardiovascular disease, including coronary artery and peripheral vascular pathologies, is the leading cause of mortality in the United States and Western countries. There is a pressing need to develop small-diameter vascular vessels for bypass surgery and other vascular reconstructive procedures. Tissue engineering offers the prospect of being able to meet the demand for replacement of diseased vessels. Significant advances have been made in recent studies and provide confidence that success is attainable. For instance, a completely cellular approach culturing cells into tissue sheets and wrapping these layers was able to form a layered cellular vascular graft with impressive strength. METHODS/

resultsIn our experiments, decellularization and heparin immobilization grafts from porcine tissues implanted in a canine model could be repopulated from the host cells, indicating the grafts' potential to develop into living tissues that can adapt and respond to changes in the body.

conclusionsThis review summarizes the current status of vascular grafts used clinically, updates the most recent developments on vascular tissue engineering, and discusses the challenges for the future.

Indexed as

Blood Vessel ProsthesisAnimalsBiocompatible MaterialsBioprosthesisBlood Vessel Prosthesis ImplantationCardiovascular DiseasesCulture TechniquesEndothelium, VascularHumansNanotechnologyPolyethylene TerephthalatesPolytetrafluoroethyleneProsthesis DesignTissue EngineeringBiocompatible MaterialsPolyethylene TerephthalatesPolytetrafluoroethylene

Identifiers

PMID17345123
OpenAlexW1977619850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.